Top compounds associated with response to SRF


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.03
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.064 0.03
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.071 0.03
mRNA lapatinib CTRPv2 pan-cancer AAC -0.078 0.04
mRNA Pazopanib FIMM pan-cancer AAC -0.36 0.04
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.04
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.04
mRNA SN-38 CTRPv2 pan-cancer AAC 0.078 0.04
mRNA PHA-793887 CTRPv2 pan-cancer AAC 0.067 0.04
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.04
Download CSV